Literature DB >> 18227181

In vitro interactions of micafungin with amphotericin B against clinical isolates of Candida spp.

Carolina Serena1, Marçal Mariné, Guillermo Quindós, Alfonso J Carrillo, J F Cano, F Javier Pastor, Josep Guarro.   

Abstract

The in vitro activity of amphotericin B in combination with micafungin was evaluated against 115 isolates representing seven species of Candida. Overall, the percentages of synergistic interactions were 50% and 20% when the MIC-2 (lowest drug concentration to cause a prominent reduction in growth) and MIC-0 (lowest drug concentration to cause 100% growth inhibition) end point criteria, respectively, were used. Antagonism was not observed. Some of the interactions were confirmed by time-kill assays.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18227181      PMCID： PMC2292525          DOI： 10.1128/AAC.01097-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.

Authors:  M Laverdiere; D Hoban; C Restieri; F Habel
Journal:  J Antimicrob Chemother       Date:  2002-07       Impact factor: 5.790

Review 2.  Advances and challenges in management of invasive mycoses.

Authors:  Thomas F Patterson
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

3.  In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.

Authors:  Danielle Swinne; Mirjam Watelle; Nicole Nolard
Journal:  Rev Iberoam Micol       Date:  2005-03       Impact factor: 1.044

4.  Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.

Authors:  Karl V Clemons; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.

Authors:  Clara Yustes; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 6.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

7.  In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula.

Authors:  Carolina Serena; Marçal Mariné; F Javier Pastor; Nicole Nolard; Josep Guarro
Journal:  J Antimicrob Chemother       Date:  2005-04-21       Impact factor: 5.790

8.  Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis.

Authors:  Carolina Serena; F Javier Pastor; Félix Gilgado; Emilio Mayayo; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

9.  Caspofungin in combination with amphotericin B against Candida parapsilosis.

Authors:  Francesco Barchiesi; Elisabetta Spreghini; Serena Tomassetti; Daniele Giannini; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

10.  In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.

Authors:  Carolina Serena; Belkys Fernández-Torres; F Javier Pastor; Luciana Trilles; Márcia Dos Santos Lazéra; Nicole Nolard; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191
View more
  5 in total

1.  Novel method for evaluating in vitro activity of anidulafungin in combination with amphotericin B or azoles.

Authors:  R Teixeira-Santos; R Rocha; A Moreira-Rosário; M Monteiro-Soares; E Cantón; A G Rodrigues; C Pina-Vaz
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

Review 2.  Micafungin for Candida albicans pacemaker-associated endocarditis: a case report and review of the literature.

Authors:  Carlo Tascini; Maria Grazia Bongiorni; Enrico Tagliaferri; Antonello Di Paolo; Sarah Flammini; Ezio Soldati; Alessandro Leonildi; Andrea Di Cori; Francesco Menichetti
Journal:  Mycopathologia       Date:  2012-10-17       Impact factor: 2.574

3.  Antifungal combinations against simulated Candida albicans endocardial vegetations.

Authors:  Manjunath P Pai
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

Review 4.  Techniques for the Assessment of In Vitro and In Vivo Antifungal Combinations.

Authors:  Anne-Laure Bidaud; Patrick Schwarz; Guillaume Herbreteau; Eric Dannaoui
Journal:  J Fungi (Basel)       Date:  2021-02-04

5.  Multicenter Collaborative Study of the Interaction of Antifungal Combinations against Candida Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis.

Authors:  Joseph Meletiadis; David R Andes; Shawn R Lockhart; Mahmoud A Ghannoum; Cindy C Knapp; Luis Ostrosky-Zeichner; Michael A Pfaller; Vishnu Chaturvedi; Thomas J Walsh
Journal:  J Fungi (Basel)       Date:  2022-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.